Neil Lerner is VP at PSYCHEMEDICS CORP (PMD). They have made 9 open-market trades across 2 companies since 2011, most recently 2026-09-24.
CIK 0001505148
6 open-market purchases totalling $164K since 2011, against 3 sales. Across 5 scored buys the stock is up 13.0% at ninety days, and 7.7 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CMPX | 400,000 | $347K |
| PMD | 25,866 | $69K |
| Total | $416K |
Shares reported on the most recent Form 4, priced at the 2026-09-25 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 100% | 100% |
| Avg Move | -4.2% | +2.4% | +13.0% |
| Alpha | -1.2% | -0.8% | +7.7% |
| Scored | 6 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMPX | BUY | 2026-09-24 | 2026-09-25 | $1.14 | $3K | -9.9% | — | — |
| CMPX | BUY | 2025-04-07 | 2025-04-08 | $1.42 | $28K | +10.6% | +10.6% | +64.0% |
| PMD | SELL | 2019-03-11 | 2019-03-13 | $15.11 | $252K | -4.1% | -4.6% | -33.6% |
| PMD | SELL | 2018-05-21 | 2018-05-23 | $20.10 | $159K | -1.2% | -3.1% | -2.0% |
| PMD | SELL | 2016-11-18 | 2016-11-21 | $24.75 | $74K | -8.0% | -7.2% | -17.0% |
| PMD | BUY | 2015-09-10 | 2015-09-14 | $10.32 | $31K | -6.4% | +0.3% | +0.3% |
| PMD | BUY | 2012-06-15 | 2012-06-19 | $9.80 | $25K | -6.4% | +0.3% | +0.3% |
| PMD | BUY | 2011-05-25 | 2011-05-26 | $10.01 | $59K | -6.4% | +0.3% | +0.3% |
| PMD | BUY | 2011-03-17 | 2011-03-21 | $9.09 | $18K | -6.4% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.